US2065593A
(en)
|
|
1936-12-29 |
|
Water-soluble diazoimino com |
FR472489A
(fr)
|
1914-02-20 |
1914-12-08 |
Stas Motor Ges M B H |
Bague de garniture métallique pour pistons
|
US2065900A
(en)
|
1935-03-23 |
1936-12-29 |
Gen Aniline Works Inc |
Dihydroxystilbene-dicarboxylic acid and a process of preparing it
|
US2071329A
(en)
|
1935-08-22 |
1937-02-23 |
Solvay Process Co |
Method of recovering phthalic anhydride
|
GB728767A
(en)
|
1951-10-12 |
1955-04-27 |
Wander Ag Dr A |
2-substituted chromone compounds, and a method of making same
|
GB726767A
(en)
|
1952-12-19 |
1955-03-23 |
Kodak Ltd |
Improvements in or relating to a web perforator
|
US3251837A
(en)
|
1962-09-14 |
1966-05-17 |
Pfizer & Co C |
Derivatives of 1, 2, 4-benzothiadiazine-1, 1-dioxides
|
GB1179019A
(en)
|
1967-05-23 |
1970-01-28 |
Produits Chimique Soc Et |
Polynicotinic Esters of Flavonoids
|
FR6928M
(xx)
|
1967-11-24 |
1969-05-05 |
|
|
US3600394A
(en)
|
1968-05-17 |
1971-08-17 |
Searle & Co |
2-aminoalkyl-3-arylisocarbostyrils
|
US3930024A
(en)
|
1969-09-02 |
1975-12-30 |
Parke Davis & Co |
Pharmaceutical compositions and methods
|
US3773946A
(en)
|
1969-09-02 |
1973-11-20 |
Parke Davis & Co |
Triglyceride-lowering compositions and methods
|
FR2244493A1
(en)
|
1973-08-09 |
1975-04-18 |
Pluripharm |
Flavonoid amino-acid salts - for treatment of haemorrhage, circulatory disorders and atherosclerosis
|
DE2349024A1
(de)
|
1973-09-26 |
1975-04-10 |
Schering Ag |
6beta,7beta-epoxy-1alpha,2alphamethylen-d-homo-4-pregnen-3,20-dione
|
US5098903A
(en)
|
1980-03-07 |
1992-03-24 |
Board Of Regents Of The University Of Oklahoma |
Diphenylcyclopropyl analogs as antiestrogenic and antitumor agents
|
IL64542A0
(en)
|
1981-12-15 |
1982-03-31 |
Yissum Res Dev Co |
Long-chain alpha,omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them
|
JPS60136512A
(ja)
|
1983-12-26 |
1985-07-20 |
Eisai Co Ltd |
脂質代謝改善剤
|
DE3423166A1
(de)
|
1984-06-22 |
1986-01-02 |
Epis S.A., Zug |
Alpha-, omega-dicarbonsaeuren, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
|
DE3579888D1
(de)
|
1984-11-08 |
1990-10-31 |
Sumitomo Pharma |
Carbapenemverbindungen und deren herstellung.
|
DE3515882A1
(de)
|
1985-05-03 |
1986-11-06 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Arzneimittel, enthaltend pyridinone mit antithrombotischen wirkungen und verfahren zu ihrer herstellung
|
DE3532279A1
(de)
|
1985-09-11 |
1987-03-12 |
Bayer Ag |
1,4-benzoxathiin-derivate
|
DE3601417A1
(de)
|
1986-01-20 |
1987-07-23 |
Nattermann A & Cie |
2'-alkyl-(alkenyl-) substituierte quercetine
|
EP0258190B1
(de)
|
1986-08-29 |
1991-11-27 |
Ciba-Geigy Ag |
Verfahren zur Herstellung von aromatischen Ether- und Thioetherverbindungen
|
DE3784147T2
(de)
|
1986-11-24 |
1993-06-03 |
Fujisawa Pharmaceutical Co |
3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-en-2-carbonsaeure-derivate.
|
GB8804058D0
(en)
|
1988-02-22 |
1988-03-23 |
Fujisawa Pharmaceutical Co |
3-alkenyl-1-azabicyclo(3 2 0)hept-2-ene-2-carboxylic acid compounds
|
US4925838A
(en)
|
1988-03-18 |
1990-05-15 |
Fujisawa Pharmaceutical Company, Ltd. |
3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
|
US4963544A
(en)
|
1988-05-23 |
1990-10-16 |
Fujisawa Pharmaceutical Company, Ltd. |
3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
|
GB8926981D0
(en)
|
1988-12-23 |
1990-01-17 |
Ici Plc |
Heterocyclic derivatives
|
AU6062590A
(en)
|
1989-07-07 |
1991-02-06 |
Schering Corporation |
Pharmaceutically active compounds
|
FR2649612A1
(fr)
|
1989-07-17 |
1991-01-18 |
Rhone Poulenc Sante |
Medicaments a base de derives de 1h-benzoxadiazine-4,1,2 nouveaux derives et leurs procedes de preparation
|
IE64358B1
(en)
|
1989-07-18 |
1995-07-26 |
Ici Plc |
Diaryl ether heterocycles
|
GB9018134D0
(en)
|
1989-09-29 |
1990-10-03 |
Ici Plc |
Heterocyclic derivatives
|
ES2098357T3
(es)
|
1990-06-05 |
1997-05-01 |
Toray Industries |
Derivado de indol.
|
JP2999579B2
(ja)
|
1990-07-18 |
2000-01-17 |
武田薬品工業株式会社 |
Dnaおよびその用途
|
GB9025832D0
(en)
|
1990-11-28 |
1991-01-09 |
Ashwell Geoffrey J |
Novel films for nonlinear optical applications
|
IE913866A1
(en)
|
1990-11-28 |
1992-06-03 |
Ici Plc |
Aryl derivatives
|
US5126351A
(en)
|
1991-01-24 |
1992-06-30 |
Glaxo Inc. |
Antitumor compounds
|
MX9200299A
(es)
|
1991-02-07 |
1992-12-01 |
Roussel Uclaf |
Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
|
CA2085136C
(en)
|
1991-04-10 |
1997-03-18 |
Ernest Kun |
Method for inhibition of retroviral replication
|
US5480883A
(en)
|
1991-05-10 |
1996-01-02 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
AU658646B2
(en)
|
1991-05-10 |
1995-04-27 |
Rhone-Poulenc Rorer International (Holdings) Inc. |
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
US5124337A
(en)
|
1991-05-20 |
1992-06-23 |
Schering Corporation |
N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme a:cholesterol acyl transferase
|
US5223506A
(en)
|
1991-06-04 |
1993-06-29 |
Glaxo Inc. |
Cyclic antitumor compounds
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
US5250679A
(en)
|
1991-10-18 |
1993-10-05 |
Genentech, Inc. |
Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
|
US5474994A
(en)
|
1992-05-26 |
1995-12-12 |
Recordati S.A., Chemical And Pharmaceutical Company |
Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
|
FR2689127B1
(fr)
|
1992-03-31 |
1994-05-06 |
Adir Cie |
Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.
|
DE4215587A1
(de)
|
1992-05-12 |
1993-11-18 |
Bayer Ag |
Sulfonylbenzyl-substituierte Benzo- und Pyridopyridone
|
DE4215588A1
(de)
|
1992-05-12 |
1993-11-18 |
Bayer Ag |
Biphenylmethyl-substituierte Pyridone
|
GB9218334D0
(en)
|
1992-08-28 |
1992-10-14 |
Ici Plc |
Heterocyclic compounds
|
JPH0680656A
(ja)
|
1992-09-03 |
1994-03-22 |
Mitsui Petrochem Ind Ltd |
光学活性エポキシドの製造方法
|
AU5850894A
(en)
|
1992-12-23 |
1994-07-19 |
Procept, Inc. |
Novel agents for inhibition of hiv infectivity and use therefor
|
JPH0741442A
(ja)
|
1993-05-21 |
1995-02-10 |
Sumitomo Chem Co Ltd |
アセチレンアルコール誘導体およびその製造法
|
JPH0761942A
(ja)
|
1993-06-17 |
1995-03-07 |
Sumitomo Chem Co Ltd |
フェノール誘導体およびその製造法
|
JPH0725761A
(ja)
|
1993-07-09 |
1995-01-27 |
Kureha Chem Ind Co Ltd |
軟骨保護剤
|
US5756763A
(en)
|
1993-07-23 |
1998-05-26 |
Zaidan Hojin Biseibutsu Kagaku Kenkyukai |
Pyrrolidine derivatives
|
US5707547A
(en)
|
1993-08-03 |
1998-01-13 |
Sumitomo Chemical Company, Limited |
Trans-olefin compounds, method for production thereof, liquid crystal composition containing the same as active ingredient, and liquid crystal element using said composition
|
JPH07118241A
(ja)
|
1993-09-01 |
1995-05-09 |
Sumitomo Chem Co Ltd |
フェノール誘導体およびその製造法
|
JPH07179380A
(ja)
|
1993-12-22 |
1995-07-18 |
Sumitomo Chem Co Ltd |
アルコール誘導体およびその製造法
|
JPH07233109A
(ja)
|
1994-02-24 |
1995-09-05 |
Sumitomo Chem Co Ltd |
光学活性なアルコール誘導体およびその製造法
|
DE69523574T2
(de)
|
1994-02-25 |
2002-05-29 |
Banyu Pharmaceutical Co., Ltd. |
Carbapenem-derivate
|
WO1995024410A1
(fr)
|
1994-03-08 |
1995-09-14 |
Otsuka Pharmaceutical Factory, Inc. |
Derive de diester phosphonique
|
JPH07247289A
(ja)
|
1994-03-11 |
1995-09-26 |
Mitsui Petrochem Ind Ltd |
クロメンオキシド類の製造方法
|
FR2718329B1
(fr)
|
1994-03-21 |
2002-09-20 |
Rhone Poulenc Rorer Sa |
Lapin transgénique sensibilisé aux dyslipoprotéinémies.
|
US6048903A
(en)
|
1994-05-03 |
2000-04-11 |
Robert Toppo |
Treatment for blood cholesterol with trans-resveratrol
|
IL109633A
(en)
|
1994-05-11 |
2005-05-17 |
Yeda Res & Dev |
Tnf receptor promoter
|
US6168776B1
(en)
|
1994-07-19 |
2001-01-02 |
University Of Pittsburgh |
Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
|
GB2292149A
(en)
|
1994-08-09 |
1996-02-14 |
Ferring Res Ltd |
Peptide inhibitors of pro-interleukin-1beta converting enzyme
|
AU711426B2
(en)
|
1994-11-14 |
1999-10-14 |
Warner-Lambert Company |
6-aryl pyrido(2,3-d)pyrimidines and naphthyridines for inhibiting protein tyrosine kinase mediated cellular proliferation
|
IL115256A0
(en)
|
1994-11-14 |
1995-12-31 |
Warner Lambert Co |
6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
|
US5446071A
(en)
|
1994-11-18 |
1995-08-29 |
Eli Lilly And Company |
Methods for lowering serum cholesterol
|
JP4140981B2
(ja)
|
1994-12-26 |
2008-08-27 |
東菱薬品工業株式会社 |
再狭窄症及び動脈硬化症治療薬
|
US5648387A
(en)
|
1995-03-24 |
1997-07-15 |
Warner-Lambert Company |
Carboxyalkylethers, formulations, and treatment of vascular diseases
|
WO1996031206A2
(en)
|
1995-04-07 |
1996-10-10 |
Warner-Lambert Company |
Flavones and coumarins as agents for the treatment of atherosclerosis
|
EP0747051B1
(en)
|
1995-06-07 |
2002-07-24 |
Eli Lilly And Company |
Treatment of diseases by inducing BEF-1 transcription factor
|
US5922866A
(en)
|
1995-08-30 |
1999-07-13 |
Otsuka Pharmaceutical Factory, Inc. |
Process for preparing quinazolin-4-one derivatives
|
US5783577A
(en)
|
1995-09-15 |
1998-07-21 |
Trega Biosciences, Inc. |
Synthesis of quinazolinone libraries and derivatives thereof
|
AU4858596A
(en)
|
1995-09-15 |
1997-04-01 |
Torrey Pines Institute For Molecular Studies |
Synthesis of quinazolinone libraries
|
AU706262B2
(en)
|
1995-10-23 |
1999-06-10 |
Osteoscreen, Inc. |
Compositions and methods for treating bone deficit conditions
|
RU2135494C1
(ru)
|
1995-12-01 |
1999-08-27 |
Санкио Компани Лимитед |
Гетероциклические соединения и композиция на их основе, проявляющая антагонистическое действие в отношении рецепторов тахикинина
|
US5756736A
(en)
|
1996-01-26 |
1998-05-26 |
Syntex (U.S.A.) Inc. |
Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
|
US5739330A
(en)
|
1996-02-05 |
1998-04-14 |
Hoechst Celanese Corporation |
Process for preparing quinazolones
|
WO1997028118A1
(en)
|
1996-02-05 |
1997-08-07 |
Hoechst Celanese Corporation |
Process for preparing anthranilic acids
|
US5763608A
(en)
|
1996-02-05 |
1998-06-09 |
Hoechst Celanese Corporation |
Process for preparing pyrimidine derivatives
|
BR9707425A
(pt)
|
1996-02-12 |
1999-07-20 |
Univ Rutgers |
Composto processo terapêutico para inibir o crescimento de células cancerosas e processo para utilizar o composto
|
AU727708B2
(en)
|
1996-06-20 |
2000-12-21 |
Board Of Regents, The University Of Texas System |
Compounds and methods for providing pharmacologically active preparations and uses thereof
|
US5854264A
(en)
|
1996-07-24 |
1998-12-29 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
KR100213895B1
(ko)
|
1996-10-14 |
1999-08-02 |
박원훈 |
감귤류 과피 추출물, 이로부터 분리 정제된 헤스페리딘 또는 나린진을 포함하는 심혈관 질환 예방및 치료제 조성물
|
DE19651099A1
(de)
|
1996-12-09 |
1998-06-10 |
Consortium Elektrochem Ind |
Mehrkomponentensystem zum Verändern, Abbau oder Bleichen von Lignin, ligninhaltigen Materialien oder ähnlichen Stoffen sowie Verfahren zu seiner Anwendung
|
IL119971A
(en)
|
1997-01-07 |
2003-02-12 |
Yissum Res Dev Co |
Pharmaceutical compositions containing dicarboxylic acids and derivatives thereof and some novel dicarboxylic acids
|
JPH10287678A
(ja)
|
1997-04-11 |
1998-10-27 |
Kyowa Hakko Kogyo Co Ltd |
ピラノアジン誘導体
|
AR012634A1
(es)
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
US5908861A
(en)
|
1997-05-13 |
1999-06-01 |
Octamer, Inc. |
Methods for treating inflammation and inflammatory disease using pADPRT inhibitors
|
IL132758A0
(en)
|
1997-05-13 |
2001-03-19 |
Octamer Inc |
Methods for treating inflammation and inflammatory diseases using padprt
|
IL133212A
(en)
|
1997-06-02 |
2005-12-18 |
Janssen Pharmaceutica Nv |
History of use (imidazolil-5-yl) methyl-2-quinolinone that act as culture inhibitors of smooth muscle cells
|
IL121165A0
(en)
|
1997-06-26 |
1997-11-20 |
Yissum Res Dev Co |
Pharmaceutical compositions containing carboxylic acids and derivatives thereof
|
GB9716812D0
(en)
|
1997-08-09 |
1997-10-15 |
Process Intelligence Limited |
Memory test equipment with optimisation function
|
US6294536B1
(en)
|
1997-08-29 |
2001-09-25 |
Takeda Schering-Plough Animal Health K.K. |
Triazine derivatives, their production and use
|
US6635642B1
(en)
|
1997-09-03 |
2003-10-21 |
Guilford Pharmaceuticals Inc. |
PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
|
US6239114B1
(en)
|
1997-09-26 |
2001-05-29 |
Kgk Synergize |
Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols
|
EP1020445B1
(en)
|
1997-10-02 |
2008-08-13 |
Eisai R&D Management Co., Ltd. |
Fused pyridine derivatives
|
CN1124134C
(zh)
|
1997-10-28 |
2003-10-15 |
韩国科学技术研究院 |
柚苷和柚苷配基作为肝病的预防或治疗剂的应用
|
GB9725782D0
(en)
|
1997-12-05 |
1998-02-04 |
Pfizer Ltd |
Therapeutic agents
|
DE19756388A1
(de)
|
1997-12-18 |
1999-06-24 |
Hoechst Marion Roussel De Gmbh |
Substituierte 2-Aryl-4-amino-chinazoline
|
ATE302267T1
(de)
|
1998-01-08 |
2005-09-15 |
Aventis Pharma Inc |
Transgenes kaninchen, dass ein funktionelles menschliches lipoprotein(a) exprimiert
|
US6414037B1
(en)
|
1998-01-09 |
2002-07-02 |
Pharmascience |
Pharmaceutical formulations of resveratrol and methods of use thereof
|
US6022901A
(en)
|
1998-05-13 |
2000-02-08 |
Pharmascience Inc. |
Administration of resveratrol to prevent or treat restenosis following coronary intervention
|
SE9802973D0
(sv)
*
|
1998-09-03 |
1998-09-03 |
Astra Ab |
Immediate release tablet
|
CA2345311A1
(en)
|
1998-09-24 |
2000-03-30 |
Kazutoshi Watanabe |
Hydroxyflavone derivatives as tau protein kinase 1 inhibitors
|
EP1123702A1
(en)
|
1998-10-19 |
2001-08-16 |
Eisai Co., Ltd. |
Analgesics
|
WO2000023073A1
(en)
|
1998-10-20 |
2000-04-27 |
Korea Institute Of Science And Technology |
Bioflavonoids as plasma high density lipoprotein level increasing agent
|
WO2000035865A2
(en)
|
1998-12-17 |
2000-06-22 |
Tularik Inc. |
Tubulin-binding agents
|
US6291456B1
(en)
|
1998-12-30 |
2001-09-18 |
Signal Pharmaceuticals, Inc. |
Compounds and methods for modulation of estrogen receptors
|
US6399633B1
(en)
|
1999-02-01 |
2002-06-04 |
Aventis Pharmaceuticals Inc. |
Use of 4-H-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation
|
AU3517700A
(en)
|
1999-03-15 |
2000-10-04 |
Abbott Laboratories |
6-o-substituted macrolides having antibacterial activity
|
US6969720B2
(en)
|
1999-03-17 |
2005-11-29 |
Amr Technology, Inc. |
Biaryl substituted purine derivatives as potent antiproliferative agents
|
US6054435A
(en)
|
1999-03-19 |
2000-04-25 |
Abbott Laboratories |
6-O-substituted macrolides having antibacterial activity
|
GB9909325D0
(en)
|
1999-04-22 |
1999-06-16 |
Gillette Co |
Pen nib
|
JP4598278B2
(ja)
|
1999-04-28 |
2010-12-15 |
サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
Ppar受容体リガンドとしてのジアリール酸誘導体
|
US6835755B1
(en)
|
1999-06-24 |
2004-12-28 |
University Of Pretoria |
Naphthoquinone derivatives and their use in the treatment and control of tuberculosis
|
DE19934799B4
(de)
|
1999-07-28 |
2008-01-24 |
Az Electronic Materials (Germany) Gmbh |
Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten
|
JP2001131151A
(ja)
|
1999-11-02 |
2001-05-15 |
Shionogi & Co Ltd |
オレフィン誘導体の新規用途
|
JP5278983B2
(ja)
|
1999-11-17 |
2013-09-04 |
塩野義製薬株式会社 |
アミド化合物の新規用途
|
JP4880847B2
(ja)
|
1999-12-06 |
2012-02-22 |
ウェリケム,バイオテック インコーポレーテッド |
ヒドロキシルスチルベンならびに新規スチルベン誘導体および類似体による抗炎症治療および乾癬治療ならびにプロテインキナーゼ阻害
|
FR2804679B1
(fr)
|
2000-02-07 |
2002-04-26 |
Clariant France Sa |
Nouveaux composes phenoliques derives des dialcoxyethanals, leur procede de preparation et leur application
|
AU775089B2
(en)
|
2000-02-17 |
2004-07-15 |
Appleton Papers Inc. |
Process for preparing alkoxy or arylmethoxy aroxyethanes
|
JP3649395B2
(ja)
|
2000-04-27 |
2005-05-18 |
山之内製薬株式会社 |
縮合ヘテロアリール誘導体
|
AU6118001A
(en)
|
2000-05-03 |
2001-11-12 |
Tularik Inc |
Combination therapeutic compositions and methods of use
|
US6548694B2
(en)
|
2000-05-23 |
2003-04-15 |
Hoffman-La Roche Inc. |
N-(4-carbamimidoyl-phenyl)-glycine derivatives
|
WO2003024441A1
(fr)
|
2001-09-14 |
2003-03-27 |
Shionogi & Co., Ltd. |
Nouvelle utilisation de composes tricycliques
|
JP2001335476A
(ja)
|
2000-05-29 |
2001-12-04 |
Shionogi & Co Ltd |
三環化合物の新規用途
|
US6479499B1
(en)
|
2000-06-28 |
2002-11-12 |
National Science Council |
2-phenyl-4-quinazolinone compounds, 2-phenyl-4-alkoxy-quinazoline compounds and their pharmaceutical compositions
|
JP2002047283A
(ja)
|
2000-07-04 |
2002-02-12 |
Basf Ag |
新規フラボノイドおよびそれらの化粧用または皮膚科用製品における使用
|
US6541522B2
(en)
|
2000-08-16 |
2003-04-01 |
Insmed Incorporated |
Methods of using compositions containing hypotriglyceridemically active stilbenoids
|
CA2356544C
(en)
|
2000-10-03 |
2006-04-04 |
Warner-Lambert Company |
Pyridotriazines and pyridopyridazines
|
MXPA03003002A
(es)
|
2000-10-05 |
2004-12-06 |
Fujisawa Pharmaceutical Co |
Compuestos de benzamina como inhibidores de la secrecion de la apo b.
|
WO2002030882A2
(en)
|
2000-10-11 |
2002-04-18 |
Esperion Therapeutics, Inc. |
Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
|
BR0114619A
(pt)
|
2000-10-11 |
2005-12-13 |
Esperion Therapeutics Inc |
Composto, composição farmacêutica, métodos para tratar ou prevenir uma doença cardiovascular, uma dislipidemia, uma dislipoproteinemia, um distúrbio do metabolismo da glicose, trombótico e associado com o receptor ativado do proliferador de peroxissoma, a doença de alzheimer, a sìndrome x ou sìndrome metabólica, a septicemia, a obesidade, pancreatite, a hipertensão, doença renal, câncer, a inflamação e a impotência, em um paciente e para reduzir o teor de gordura da carne em animal de criação e de colesterol de ovos de aves domésticas
|
EP1333827A2
(en)
|
2000-10-19 |
2003-08-13 |
Merck & Co., Inc. |
Estrogen receptor modulators
|
EP1881050B1
(en)
|
2000-11-30 |
2013-01-09 |
Canon Kabushiki Kaisha |
Luminescence device and display apparatus
|
US6593612B2
(en)
|
2000-12-05 |
2003-07-15 |
Infineon Technologies Ag |
Structure and method for forming a body contact for vertical transistor cells
|
RU2003120061A
(ru)
|
2000-12-07 |
2004-11-27 |
Си Ви Терапьютикс, Инк. (Us) |
Замещенные 1,3,5-триазины и пиримидины в качестве повышающих авса-1 соединений против заболевания коронарной артерии или атеросклероза
|
KR100472694B1
(ko)
|
2000-12-30 |
2005-03-07 |
한국생명공학연구원 |
플라바논 유도체 및 이를 포함하는 혈중 지질 농도 관련질환의 예방 및 치료용 조성물
|
JP2002249483A
(ja)
|
2001-02-21 |
2002-09-06 |
Koei Chem Co Ltd |
アリール置換複素環式化合物の製造法
|
JP4786040B2
(ja)
|
2001-02-23 |
2011-10-05 |
独立行政法人科学技術振興機構 |
キラル補助基を効率的に除去する光学活性化合物の製造方法
|
WO2002074307A1
(en)
|
2001-03-16 |
2002-09-26 |
Novogen Research Pty Ltd |
Treatment of restenosis
|
AU2002320025A1
(en)
|
2001-04-11 |
2002-11-11 |
Atherogenics, Inc. |
Probucol monoesters and their use to increase plasma hdl cholesterol levels and improve hdl functionality
|
ATE445400T1
(de)
|
2001-05-25 |
2009-10-15 |
Bristol Myers Squibb Co |
Hydantion-derivate als hemmer von matrix- metalloproteinasen
|
WO2003007959A1
(en)
|
2001-07-16 |
2003-01-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinoxaline derivatives which have parp inhibitory action
|
US7173128B2
(en)
|
2001-08-13 |
2007-02-06 |
Ciba Specialty Chemicals Corporation |
Ultraviolet light absorbers
|
EP1419770A4
(en)
|
2001-08-24 |
2005-08-03 |
Shionogi & Co |
AGENT ACC L RATION OF THE EXPRESSION OF APO AI
|
US7429593B2
(en)
|
2001-09-14 |
2008-09-30 |
Shionogi & Co., Ltd. |
Utilities of amide compounds
|
US8124625B2
(en)
|
2001-09-14 |
2012-02-28 |
Shionogi & Co., Ltd. |
Method of enhancing the expression of apolipoprotein AI using olefin derivatives
|
US6835469B2
(en)
|
2001-10-17 |
2004-12-28 |
The University Of Southern California |
Phosphorescent compounds and devices comprising the same
|
US7166368B2
(en)
|
2001-11-07 |
2007-01-23 |
E. I. Du Pont De Nemours And Company |
Electroluminescent platinum compounds and devices made with such compounds
|
US7250512B2
(en)
|
2001-11-07 |
2007-07-31 |
E. I. Du Pont De Nemours And Company |
Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
|
US6541045B1
(en)
|
2002-01-04 |
2003-04-01 |
Nutraceutical Corporation |
Herbal composition and method for combating inflammation
|
WO2003064399A1
(fr)
|
2002-01-28 |
2003-08-07 |
Ube Industries, Ltd. |
Procede de production de derive de quinazolin-4-one
|
CA2476822A1
(en)
|
2002-02-19 |
2003-08-28 |
Pharmacia Italia S.P.A. |
Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
|
MY140680A
(en)
|
2002-05-20 |
2010-01-15 |
Bristol Myers Squibb Co |
Hepatitis c virus inhibitors
|
AU2003238157A1
(en)
|
2002-06-18 |
2003-12-31 |
Sankyo Company, Limited |
Fused-ring pyrimidin-4(3h)-one derivatives, processes for the preparation and uses thereof
|
KR20040001144A
(ko)
|
2002-06-27 |
2004-01-07 |
김대경 |
신규한 적혈구 세포질형 포스포리파아제 에이 투 효소,그에 대한 항체, 이들의 용도 및 제조 방법
|
US20050080024A1
(en)
|
2002-08-15 |
2005-04-14 |
Joseph Tucker |
Nitric oxide donating derivatives for the treatment of cardiovascular disorders
|
US20050080021A1
(en)
|
2002-08-15 |
2005-04-14 |
Joseph Tucker |
Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders
|
US20040033480A1
(en)
|
2002-08-15 |
2004-02-19 |
Wong Norman C.W. |
Use of resveratrol to regulate expression of apolipoprotein A1
|
CA2495903A1
(en)
|
2002-08-23 |
2004-03-04 |
University Of Connecticut |
Novel biphenyl and biphenyl-like cannabinoids
|
AU2003262946A1
(en)
|
2002-08-30 |
2004-03-19 |
Pharmacia And Upjohn Company |
Method of preventing or treating atherosclerosis or restenosis
|
EP1398032A1
(en)
|
2002-09-10 |
2004-03-17 |
PheneX Pharmaceuticals AG |
4-Oxo-quinazolines as LXR nuclear receptor binding compounds
|
EP1407774A1
(en)
|
2002-09-10 |
2004-04-14 |
LION Bioscience AG |
2-Amino-4-quinazolinones as LXR nuclear receptor binding compounds
|
WO2004032846A2
(en)
|
2002-10-07 |
2004-04-22 |
Bristol-Myers Squibb Company |
Triazolone and triazolethione derivatives
|
US20040132732A1
(en)
|
2002-10-21 |
2004-07-08 |
Wei Han |
Quinazolinones and derivatives thereof as factor Xa inhibitors
|
WO2004039795A2
(en)
|
2002-10-29 |
2004-05-13 |
Fujisawa Pharmaceutical Co., Ltd. |
Amide compounds for the treatment of hyperlipidemia
|
EP1418164A1
(en)
|
2002-11-07 |
2004-05-12 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonists
|
DE60327097D1
(de)
|
2002-11-18 |
2009-05-20 |
Hoffmann La Roche |
Diazinopyrimidine und ihre verwendung als proteinkinaseinhibitoren
|
CN1753897A
(zh)
|
2002-11-22 |
2006-03-29 |
日本烟草产业株式会社 |
稠合双环含氮杂环
|
DE60307512T2
(de)
|
2002-12-13 |
2007-02-08 |
F. Hoffmann-La Roche Ag |
3h-chinazoline -4-on derivaten
|
ITRM20020629A1
(it)
|
2002-12-19 |
2004-06-20 |
Sigma Tau Ind Farmaceuti |
Uso di acidi alfa-feniltiocarbossilici e alfa-fenilossicarbossilici ad attivita' ipoglicemizzante e/o ipolipidemizzante.
|
WO2004058717A1
(en)
|
2002-12-20 |
2004-07-15 |
X-Ceptor Therapeutics, Inc. |
Isoquinolinone derivatives and their use as therapeutic agents
|
JP2004203751A
(ja)
|
2002-12-24 |
2004-07-22 |
Pfizer Inc |
置換6,6−ヘテロ二環式誘導体
|
CA2512000C
(en)
|
2002-12-26 |
2011-08-09 |
Eisai Co., Ltd. |
Selective estrogen receptor modulator
|
WO2004065392A1
(en)
|
2003-01-24 |
2004-08-05 |
Smithkline Beecham Corporation |
Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands
|
WO2004072042A2
(en)
|
2003-02-12 |
2004-08-26 |
Carex S.A. |
Quinoline derivative and their use for modulation of lxr activity
|
EP1615906A1
(en)
|
2003-04-03 |
2006-01-18 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
AU2004230928B2
(en)
|
2003-04-09 |
2010-12-02 |
Exelixis, Inc. |
Tie-2 modulators and methods of use
|
JP2004307440A
(ja)
|
2003-04-10 |
2004-11-04 |
Kyorin Pharmaceut Co Ltd |
2−アミノ‐1,3‐プロパンジオール誘導体とその付加塩
|
WO2004094452A2
(en)
|
2003-04-16 |
2004-11-04 |
Bristol-Myers Squibb Company |
Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus
|
CA2525383C
(en)
|
2003-06-06 |
2012-03-06 |
Arexis Ab |
Use of heterocyclic compounds as scce inhibitors
|
EP1633718B1
(en)
|
2003-06-17 |
2012-06-06 |
Millennium Pharmaceuticals, Inc. |
COMPOSITIONS AND METHODS FOR INHIBITING TGF-s
|
JP4631703B2
(ja)
|
2003-06-18 |
2011-02-16 |
宇部興産株式会社 |
ピリミジン−4−オン化合物の製造方法
|
US20050043300A1
(en)
|
2003-08-14 |
2005-02-24 |
Pfizer Inc. |
Piperazine derivatives
|
CN1925862A
(zh)
|
2003-10-10 |
2007-03-07 |
雷斯弗洛吉克斯公司 |
与egr-1增强子元件有关的疾病的治疗
|
KR20070026306A
(ko)
|
2003-10-28 |
2007-03-08 |
레디 유에스 테라퓨틱스 인코포레이티드 |
헤테로시클릴 화합물 및 그의 제조방법과 그의 용도
|
JP2007517071A
(ja)
|
2003-12-19 |
2007-06-28 |
メルク エンド カムパニー インコーポレーテッド |
有糸分裂キネシン阻害剤
|
WO2005066162A1
(en)
|
2003-12-23 |
2005-07-21 |
Human Biomolecular Research Institute |
Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer
|
US20050167025A1
(en)
|
2004-01-06 |
2005-08-04 |
Toshikazu Kobayashi |
Process for laser welding polyester compositions
|
TW200536830A
(en)
|
2004-02-06 |
2005-11-16 |
Chugai Pharmaceutical Co Ltd |
1-(2H)-isoquinolone derivative
|
JPWO2005115993A1
(ja)
|
2004-05-31 |
2008-03-27 |
萬有製薬株式会社 |
キナゾリン誘導体
|
WO2006012577A2
(en)
|
2004-07-22 |
2006-02-02 |
Bayer Pharmaceuticals Corporation |
Quinazolinone derivatives useful for the regulation of glucose homeostasis and food intake
|
US20070218155A1
(en)
|
2004-08-20 |
2007-09-20 |
Kuhrts Eric H |
Methods and compositions for treating dyslipidaemia
|
US8093273B2
(en)
|
2004-10-20 |
2012-01-10 |
Resverlogix Corp. |
Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
|
US20080152595A1
(en)
*
|
2004-11-24 |
2008-06-26 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
EP1844023A1
(en)
|
2004-12-31 |
2007-10-17 |
Sk Chemicals Co., Ltd. |
Quinazoline derivatives for the treatment and prevention of diabetes and obesity
|
CR9465A
(es)
|
2005-03-25 |
2008-06-19 |
Surface Logix Inc |
Compuestos mejorados farmacocineticamente
|
KR101431279B1
(ko)
|
2005-07-29 |
2014-08-20 |
리스버로직스 코퍼레이션 |
복합 질환의 예방 및 치료용 약학적 조성물 및 삽입가능한의료 장치에 의한 이의 전달
|
WO2007049798A1
(ja)
|
2005-10-27 |
2007-05-03 |
Banyu Pharmaceutical Co., Ltd. |
新規ベンゾオキサチイン誘導体
|
KR20080089416A
(ko)
|
2005-12-21 |
2008-10-06 |
페인셉터 파마 코포레이션 |
개폐 이온 통로를 조절하기 위한 조성물 및 방법
|
EP1928425B1
(en)
|
2006-05-12 |
2013-01-23 |
Pharmathen S.A. |
Pharmaceutical formulation containing fluvastatin
|
WO2008044236A2
(en)
*
|
2006-10-10 |
2008-04-17 |
Dexcel Pharma Technologies Ltd. |
Improved release of statins in the intestine
|
ES2454966T3
(es)
|
2007-02-01 |
2014-04-14 |
Resverlogix Corp. |
Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
|
EP2005941A3
(de)
|
2007-06-01 |
2009-04-01 |
Henkel AG & Co. KGaA |
Zellverjüngende Zusammensetzungen
|
WO2008152471A1
(en)
|
2007-06-12 |
2008-12-18 |
Coley Pharmaceutical Group, Inc. |
Quinazoline derivative useful as toll-like receptor antagonist
|
CA2710740C
(en)
|
2007-12-28 |
2016-07-19 |
Shinji Miyoshi |
Thienotriazolodiazepine compound as antitumor agent
|
RU2520098C2
(ru)
*
|
2008-06-26 |
2014-06-20 |
Ресверлоджикс Корп. |
Способы получения производных хиназолинона
|
CA2732087A1
(en)
|
2008-08-05 |
2010-02-11 |
Boehringer Ingelheim International Gmbh |
Substituted naphthyridines and their use as medicaments
|
AU2009302473A1
(en)
|
2008-10-06 |
2010-04-15 |
Carolus Therapeutics, Inc. |
Methods of treating inflammation
|
WO2010079431A2
(en)
|
2009-01-08 |
2010-07-15 |
Resverlogix Corp. |
Compounds for the prevention and treatment of cardiovascular disease
|
MX2011008641A
(es)
|
2009-03-06 |
2011-09-06 |
Hoffmann La Roche |
Compuestos heterociclicos antivirales.
|
NZ595747A
(en)
|
2009-03-18 |
2015-06-26 |
Resverlogix Corp |
Novel quinazolinones and related compounds for use as anti-inflammatory agents
|
KR20190091564A
(ko)
|
2009-04-22 |
2019-08-06 |
리스버로직스 코퍼레이션 |
신규한 소염제
|
NZ624963A
(en)
*
|
2009-04-29 |
2016-07-29 |
Amarin Pharmaceuticals Ie Ltd |
Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
|
DE102010048800A1
(de)
|
2010-10-20 |
2012-05-10 |
Merck Patent Gmbh |
Chinoxalinderivate
|
GB201018147D0
(en)
|
2010-10-27 |
2010-12-08 |
Glaxo Group Ltd |
Method of treatment
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
US9328117B2
(en)
|
2011-06-17 |
2016-05-03 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
PT2773354T
(pt)
|
2011-11-01 |
2019-07-17 |
Resverlogix Corp |
Formulações orais de libertação imediata para quinazolinonas substituídas
|
US20130281397A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
US9624244B2
(en)
|
2012-06-06 |
2017-04-18 |
Constellation Pharmaceuticals, Inc. |
Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
|
WO2014060852A2
(en)
|
2012-10-15 |
2014-04-24 |
Resverlogix Corp. |
Compounds useful in the synthesis of benzamide compounds
|
WO2014080290A2
(en)
|
2012-11-21 |
2014-05-30 |
Rvx Therapeutics Inc. |
Cyclic amines as bromodomain inhibitors
|
WO2014096965A2
(en)
|
2012-12-21 |
2014-06-26 |
Rvx Therapeutics Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
JP6401773B2
(ja)
|
2013-03-11 |
2018-10-10 |
ザ リージェンツ オブ ザ ユニヴァシティ オブ ミシガン |
Betブロモドメイン阻害剤およびこれを用いる治療方法
|
CN105407894A
(zh)
|
2013-03-14 |
2016-03-16 |
康威基内有限公司 |
用于抑制含布罗莫结构域的蛋白质的方法和组合物
|
TWI530499B
(zh)
|
2013-03-28 |
2016-04-21 |
吉李德科學股份有限公司 |
作為溴結構域(bromodomain)抑制劑之苯並咪唑酮衍生物類
|
KR20160043118A
(ko)
|
2013-08-21 |
2016-04-20 |
리스버로직스 코퍼레이션 |
가속화된 경화반 퇴행을 위한 조성물 및 치료방법
|
US20160206617A1
(en)
|
2013-08-21 |
2016-07-21 |
Resverlogix Corp. |
Compositions and therapeutic methods for accelerated plaque regression
|